Navigation Links
Chimerix Announces Late-Breaker Presentation at 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Annual Meeting
Date:9/16/2011

DURHAM, N.C., Sept. 16, 2011 /PRNewswire/ -- Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, announced today that investigators will present preliminary data for CMX001 in a late-breaker presentation at the 51st Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC, Chicago – September 17-20).  

Genovefa Papanicolaou, M.D., Associate Member of Infectious Diseases Service at Memorial Sloan-Kettering Cancer Center and one of the lead investigators in Chimerix's ongoing Phase 2 cytomegalovirus (CMV) study, will give a presentation entitled, "CMX001 is not nephrotoxic or myelosuppressive in 183 patients with life threatening dsDNA infections including refractory Cytomegalovirus, Adenovirus, and BK Virus," on Sunday, September 18 at 8:30 am CDT.  Immediately following Dr. Papanicolaou's presentation, Richard Whitley, M.D., Distinguished Professor at The University of Alabama at Birmingham, will present "New Antivirals for Herpes Viruses: What Can We Look Forward to and When?," which highlights CMX001. Both presentations are part of the "Herpes and Other Viruses" slide session that begins at 8:30 am CDT.  In accordance with ICAAC embargo policy, these data remain under embargo until conclusion of the late-breaker session on Sunday, September 18 at 11:00 am CDT.  

Data from Dr. Papanicolaou's presentation was generated as part of Chimerix's expanded access program, through which Chimerix has dosed over 300 subjects with CMX001 since March 2009, including 183 subjects under investigator-held Emergency Investigational New Drug applications (EINDs) or foreign equivalents at over 80 medical centers in the United States, Canada, Europe, and Israel.  Through EINDs, CMX001 has been used for the treatment of a wide range of life-threatening infections caused by dsDNA viruses, including CMV, adenovirus (AdV), BK virus (BKV), Epstein Barr virus (EBV), herpes simplex v
'/>"/>

SOURCE Chimerix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Chimerix Initiates a Multi-dose Clinical Trial of the Companys Lead Compound, CMX001, for the Treatment for Smallpox Infection
2. Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox
3. Chimerix to Present at Two Upcoming Investor Conferences
4. Chimerix CEO George Painter, Ph.D., to Speak on Improving Biodefense Product Discovery and Development Strategies at Institute of Medicine Workshop
5. Chimerix Initiates Phase 2 Study of CMX001 in Stem Cell Transplant Recipients Seropositive for Cytomegalovirus
6. Chimerix Appoints Thomas Pitler, Ph.D., Vice President, Business Development
7. Chimerix to Present at 9th Annual BIO Investor Forum
8. Chimerix Reaffirms Its Commitment to CMX001 as a Medical Countermeasure for Smallpox and Broad-Spectrum Antiviral Agent
9. Chimerix to Present at the Lazard Capital Markets 7th Annual Healthcare Conference
10. Chimerixs Antiviral CMX157 Demonstrates Positive Phase 1 Clinical Results With Favorable Pharmacokinetics, Safety and Tolerability
11. Chimerix Commences CMX001 Open-Label Clinical Study for the Treatment of Patients With Life-Threatening or Serious dsDNA Viral Infections
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... , Aug. 28, 2014 Levi & Korsinsky ... in the United States District Court for the District ... investors who purchased Galectin Therapeutics Inc. ("Galectin" or the ... July 28, 2014. For more information, click ... that during the Class Period the Company violated federal ...
(Date:8/28/2014)... , August 28, 2014 ... "DNA diagnostics Market (products, applications, techniques, end users ... Growth and Forecast, 2013 - 2020," indicates that ... billion by 2020 registering a CAGR of 9.8% ... accurate diagnosis and cost effectiveness over alternative diagnostic ...
(Date:8/28/2014)... /PRNewswire-iReach/ -- Gateway Analytical announced today that they ... Annual Global Pharma Manufacturing Summit in ... The Global Pharma Manufacturing Summit offers a networking ... biologic pharmaceutical manufacturing. The conference is focused on ... such as the increasing pressure to grow and ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Galectin Therapeutics Inc. and Its Board of Directors and a Lead Plaintiff Deadline of September 29, 2014 -- GALT 2DNA Diagnostics Market is Expected to Reach $19 Billion by 2020 - Allied Market Research 2DNA Diagnostics Market is Expected to Reach $19 Billion by 2020 - Allied Market Research 3Gateway Analytical to Promote Particulate Identification Services at the 9th Annual Global Pharma Manufacturing Summit 2Gateway Analytical to Promote Particulate Identification Services at the 9th Annual Global Pharma Manufacturing Summit 3
... May 6, 2011 CryoLife, Inc. (NYSE: ... tissue processing company, today announced the final results of ... owned subsidiary CL Falcon, Inc., for 49.9 percent of ...  The tender offer expired at 12:00 midnight, Eastern Time, ...
... Ferring Pharmaceuticals Inc., the makers of FIRMAGON® (degarelix for injection), ... the race to end prostate cancer as an official sponsor ... growing men,s health event series in the United States. Now ... (GPCC) is led by ZERO – The Project to ...
Cached Medicine Technology:CryoLife Announces Final Results of Tender Offer for 49.9 Percent of the Outstanding Shares of Cardiogenesis Corporation 2CryoLife Announces Final Results of Tender Offer for 49.9 Percent of the Outstanding Shares of Cardiogenesis Corporation 3CryoLife Announces Final Results of Tender Offer for 49.9 Percent of the Outstanding Shares of Cardiogenesis Corporation 4CryoLife Announces Final Results of Tender Offer for 49.9 Percent of the Outstanding Shares of Cardiogenesis Corporation 5CryoLife Announces Final Results of Tender Offer for 49.9 Percent of the Outstanding Shares of Cardiogenesis Corporation 6Ferring Pharmaceuticals to Support Great Prostate Cancer Challenge® Events Across the Country in National Effort to End Prostate Cancer 2Ferring Pharmaceuticals to Support Great Prostate Cancer Challenge® Events Across the Country in National Effort to End Prostate Cancer 3
(Date:8/28/2014)... sleep not only puts teens at risk for poor grades, ... warn. The study authors analyzed data collected from more ... Nearly one-fifth of them got less than six hours of ... group was 20 percent more likely to be obese at ... of sleep per night at age 16, the investigators found. ...
(Date:8/28/2014)... wing? Did they fall from trees and learn to flap ... the ground and pump their "arms" to get aloft? , ... but a new University of California, Berkeley, study provides a ... to maneuver in midair, a talent that could have helped ... perch. , The study looked at how baby birds, in ...
(Date:8/28/2014)... August 28, 2014 NJ Top ... of North Jersey. , NJ Top Doc, Dr. ... now a certified medical examiner for the department ... by the department to perform all drug testing ... in diagnosing and treating musculoskeletal disorders including disk ...
(Date:8/28/2014)... 28, 2014 (BRONX, NY) Researchers from Albert ... institutions have developed a potential antibody therapy for Sudan ebolavirus ... A different strain, the Zaire ebolavirus (EBOV), is now devastating ... Ebola outbreaks (most recently in 2012) that have ... reported in ACS Chemical Biology . , Between ...
(Date:8/28/2014)... Aug. 28, 2014 In 2012, The ... in grants for two groundbreaking brain cancer research ... One of those projects has officially received the ... Francisco, which means patient enrollment for the trial ... "Genomics Enabled Medicine in Glioblastoma Trial," TGen and ...
Breaking Medicine News(10 mins):Health News:Less Sleep in Teen Years Tied to More Pounds at 21 2Health News:Flapping baby birds give clues to origin of flight 2Health News:Flapping baby birds give clues to origin of flight 3Health News:NJ Top Docs Presents Dr. Christophe Oliveira of Rehabilitation Instiute of North Jersey 2Health News:NJ Top Docs Presents Dr. Christophe Oliveira of Rehabilitation Instiute of North Jersey 3Health News:Drug shows promise against Sudan strain of Ebola in mice 2Health News:TGen receives approval for patient enrollment in brain cancer clinical trial 2
... and CHICAGO, Jan. 14 Aon ... advisor, released today a preliminary forecast of direct ... Ponzi scheme.(Logo: http://www.newscom.com/cgi-bin/prnh/20041215/CGW049LOGO )"While the maximum ... over $6 billion, the range of direct insured ...
... who want a baby, study says, , , WEDNESDAY, Jan. 14 (HealthDay ... vitro fertilization have up to an 86 percent chance of giving ... the odds are less than 50 percent -- in some cases, ... infertility, and it can overcome most causes of infertility for those ...
... Chaka Fattah (D-PA) issues the following statement upon passage by ... by a bipartisan vote of 289 to 139. ... to bring change to Washington by expanding health care for ... today. I have joined with more than two-thirds of my ...
... treatment of liver disease, study says , , WEDNESDAY, Jan. 14 ... not appear to help Hispanic whites with the liver disease ... suggests. , This is second major ethnic group -- the ... the therapy, consisting of pegylated interferon with ribavirin, in recent ...
... is being adopted in the U.S. and around the world, ... simple checklist that ensures everyone in the operating room is ... report. , The need for improving safety in surgery is ... each year, 60 million of them in the United States. ...
... National Council of Legislators from Gaming States ( ... states with casinos and other forms of state-regulated ... encouraging states to take action to make all ... NCLGS 2009 Winter Meeting, held last weekend in ...
Cached Medicine News:Health News:Aon Benfield Forecasts Potential Impact on the Insurance Industry Resulting From the Alleged Madoff Scandal 2Health News:IVF Treatments Often Work for Women Under 35 2Health News:IVF Treatments Often Work for Women Under 35 3Health News:Hispanics Respond Poorly to Standard Hepatitis C Therapy 2Health News:Surgeon's Checklist Saves Lives 2Health News:Surgeon's Checklist Saves Lives 3Health News:National Council of Legislators From Gaming States Adopts Resolution Supporting 100% Smokefree Gaming Venues 2
... The Devex Mesh System is indicated for ... a diseased vertebral body resected or excised for ... of the spinal cord and neural tissues, and ... body. Devex Mesh System is also indicated for ...
... Ocelot stackable cage system provides anterior column ... total vertebrectomies from T1 to L5. The ... Carbon fiber polymer cages that are stacked ... needs. The Peek Carbon fiber reinforced polymer ...
... Vitoss engineered to resemble ... and structure. -TCP constructs ... in spinal arthrodesis surgery ... due to trauma and ...
... system provides anterior column support for single ... T1 to L5. The system consists of ... cages that are stacked to a desired ... Carbon fiber reinforced polymer material emulates the ...
Medicine Products: